Tag: cáncer de pulmón
-
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)
agosto 29, 2022Abstract Introduction: Osimertinib is a third generation EGFR-TKI inhibitor approved in the first-line setting for patients with advanced non-small cell lung…
-
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP)
agosto 29, 2022Abstract Objectives: To compare the rate disparity between outcomes (overall survival (OS), progression-free survival (PFS), and safety) of concurrent chemoradiation…
-
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
junio 4, 2022Abstract Background: Mutations in STK11 (STK11Mut) and, frequently co-occurring, KEAP1 mutations (KEAP1Mut) are associated with poor survival in metastatic Non-small…
-
HEALTH Uniting Latin America Through Research: How Regional Research Can Strengthen Local Policies, Networking, and Outcomes for Patients With Lung Cancer
mayo 4, 2022Resumen: Lung cancer represents a considerable global health threat, leading the list in terms of cancer-related deaths worldwide. An important…
-
Circulating T regulatory cell subsets in patients with untreated lung cancer
abril 1, 2022Circulating T regulatory cell subsets in patients with untreated lung cancer
-
Real‐world evaluation of molecular testing and treatment patterns for EGFR mutations in non‐small cell lung cancer in Latin America
enero 4, 2022Abstract: Lung cancer is a leading cause of cancer‑related deaths in Latin America, with non‑small cell lung cancer (NSCLC) being…